Human cytomegalovirus (HCMV), a member of the b-subgroup of herpesviruses, represents a wide-spread human pathogen that may cause severe disease, especially in immunosuppressed individuals (de la Hoz et al., 2002) . Viral infection is counteracted by intrinsic, innate and adaptive immune mechanisms. While the latter two require pathogen induced signal cascades for activation, intrinsic immunity is characterized by constitutively expressed cellular proteins that may be upregulated in response to infection; however, their activity does not require any virus-triggered signalling, thus forming a front-line defence against viral attack (Bieniasz, 2004) . A subnuclear structure, known as nuclear domain 10 [ND10; alternatively termed promyelocytic leukaemia protein (PML) nuclear bodies)] has previously been reported to mediate intrinsic immunity against herpesviruses (for reviews see Everett & Chelbi-Alix, 2007; Tavalai & Stamminger, 2008 , 2010 . ND10 are defined as subnuclear structures that are located within the interchromosomal space of the nucleus, representing an accumulation of more than 70 cellular proteins (Van Damme et al., 2010) . The PML is the defining constituent of this domain, because it serves as a scaffold protein (Ishov et al., 1999; Zhong et al., 2000) . PML and hDaxx, which is the second major ND10 component, have both been identified in previous studies as restriction factors counteracting human cytomegaloviral infections (Preston & Nicholl, 2006; Saffert & Kalejta, 2006; Tavalai et al., 2006 Tavalai et al., , 2008 Woodhall et al., 2006) . The Sp100 protein (speckle protein of 100 kDa) forms the third major ND10 constituent and can, likewise to PML and hDaxx, be detected in association with ND10 structures in most cells. Sp100 was first described as an antigen in autoimmune disorders (Szostecki et al., 1990) . Alternative splicing from a single gene results in four different isoforms, named Sp100-A, -B, -C and -HMG (Andreoni et al., 1989; Dent et al., 1996; Guldner et al., 1999; Seeler et al., 2001; Szostecki et al., 1990) , sharing a homologous N terminus, but differing in their C-terminal part (Fig. 1a) . Interestingly, Sp100, like PML, is upregulated by treatment of cells with interferon (Guldner et al., 1992; Lavau et al., 1995; Stadler et al., 1995) , suggesting a role for this protein in the defence against pathogens. In this study, we asked whether Sp100 can also act as a cellular restriction factor for HCMV infection. Furthermore, we were interested in analysing whether Sp100 exerts any functions in concert with PML or hDaxx.
In order to investigate the impact of Sp100 on HCMV infection, we generated Sp100-depleted primary human fibroblast cells (HFFs). In recent publications, four distinct Sp100-isoforms were described (Cuchet et al., 2011; Everett et al., 2008; Negorev et al., 2009) . Consequently, a short hairpin RNA (shRNA) sequence targeting all known isoforms was selected and cloned into the retroviral small interfering RNA (siRNA)-expression vector pSiren-RetroQThese cells behaved like normal HFFs, with regard to growth and morphology. Cells containing the empty vector pSiren-RetroQ (vector) or a functionally inactive half-side shRNA sequence (siC) were produced as described previously (Tavalai et al., 2008) and served as control cell lines. All cells were generated in parallel and the knock- down (kd) of endogenous proteins was analysed by Western blotting, which revealed loss of all Sp100-isoforms to ,0.5 % of endogenous protein levels in siSp100 cells compared with vector-and siC-cells, respectively (Fig. 1b, upper panel; Fig. 1c) . To further confirm the Sp100-kd, indirect immunofluorescence analyses were performed (Fig. 1d) . Vector-, siC-and siSp100-cells were cultivated on coverslips and stained for the presence of endogenous PML and Sp100 using a mouse monoclonal anti-PML antibody (PG-M3; Santa Cruz Biotechnology) together with a rabbit polyclonal anti-Sp100 antiserum (H60; Santa Cruz Biotechnology). As expected, PML and Sp100 appeared in dot-like structures in the nucleus and colocalized with each other in control cells [ Fig. 1d , (i)-(iv) and (v)-(viii)]. The siSp100-cells revealed a complete loss of Sp100, however, the subnuclear localization of endogenous PML was not affected [Fig. 1d , (ix)-(xii)]. As a first experiment to investigate the effect of Sp100-depletion on HCMV replication, Sp100-kd fibroblasts together with control fibroblasts were infected with the recombinant HCMV AD169-GFP (m.o.i. of 0.002), expressing enhanced green fluorescent protein (Marschall et al., 2000) . Thereafter, viral replication was assessed at 7 and 10 days post-infection (p.i.) by GFP quantification via automated fluorometry as described previously (Marschall et al., 2000) . As shown in Fig. 1(e) , we could detect significantly more GFP-fluorescence in Sp100-kd cells at 7 days p.i., indicating enhanced replication of HCMV in the absence of Sp100.
To further investigate whether the kd of Sp100 had any effect on the abundance or isoform-specific expression of the other major ND10 components, cell lysates of Sp100-, PML-and hDaxx-kd cells were subjected to Western blot analysis (Fig. 2a) . The PML-kd (siPML) and hDaxx-kd (siDaxx) cells were generated as published previously (Tavalai et al., 2006) . Endogenous protein levels of Sp100 showed a clear loss of all isoforms in siSp100-cells, as shown in the upper panel of Fig. 2(a) . Similarly, the hDaxx- (Fig. 2a , middle panel, lane 5) and PML-protein levels (Fig. 2a, lower panel, lane 4) were extensively reduced in the respective kd-cell lines. Conclusively, the shRNA sequence against Sp100 had no effect on protein levels of other ND10 components. Interestingly, the pattern of Sp100-isoforms changed in siPML-cells, resulting in a higher amount of Sp100-A instead of Sp100-A-SUMO and a reduction of the low mobility Sp100-isoforms (Fig. 2a,  upper panel, lane 4) , which is consistent with results published in previous studies (Cuchet et al., 2011; Everett et al., 2008) .
The main motivation for this study was to determine whether the depletion of Sp100 affects the replication of human cytomegalovirus in a similar manner as the kd of PML or hDaxx. Consequently, infection experiments were performed with the generated kd-cells. Since previous studies had demonstrated a significant increase in HCMV immediate-early (IE) gene expression in the absence of the ND10 proteins PML or hDaxx (Cantrell & Bresnahan, 2006 (Andreoni et al., 1989) . Similar to PMLand hDaxx-kd cells, a four-to fivefold higher number of IE1-expressing cells was detected in Sp100-deficient cells compared with control fibroblasts (Fig. 2b) . Since we wanted to know whether IE1-positive cells progressed in their replicative cycle, plaque assays were performed in parallel and the number of plaques were determined 7 days p.i. (Fig. 2c) . Although the overall increase of plaque number was slightly lower compared with the increase of IE1-expressing cells, there was nevertheless a clearly detectable difference between kd and control cells. This indicates that the kd of Sp100, PML or hDaxx not only affected the initiation of IE gene expression, but IE1-expressing cells were also able to produce infectious virus particles. Interestingly, the effect was slightly higher in siSp100 kd-cells compared with the kd of PML or hDaxx, respectively (Fig. 2c ).
Previously, we were able to show that PML and hDaxx independently contribute to the repressive effect of ND10 on HCMV gene expression (Tavalai et al., 2008) . Consequently, we decided to clarify if this is also true for Sp100. To address this issue, we generated HFFs in which either a combination of Sp100 and hDaxx or Sp100 and PML proteins were depleted, respectively. For the depletion of Sp100 and hDaxx, first an hDaxx kd was established. Then, a second retroviral transduction was performed with a pSiren-RetroQ-vector expressing the shRNA targeting Sp100, which resulted in HFFs where both Sp100 and hDaxx were highly suppressed. Lysates of the various cell lines were subjected to Western blotting and analysed for endogenous protein levels, as indicated in Fig. 3(a) : the upper panel reveals a complete loss of all Sp100-isoforms in siSp100 and siDaxx+siSp100 cells (Fig. 3a, lanes 4 and 5) compared with control fibroblasts (Fig. 3a, lanes 1 and 2) . In addition, we detected an extensive depletion of hDaxx in siDaxx-and siDaxx+siSp100-cells (Fig. 3a, middle panel,  lanes 3 and 5) . To generate the Sp100/PML-kd cell line, we started with HFFs, already lacking Sp100, which were subsequently transduced using an shRNA-expression vector against PML. This resulted in double-kd cells with a depletion of Sp100 as well as of PML. Fig. 3(b) , shows the Western blot analysis performed with cell lysates of the resulting kd-lines compared with controls revealing a complete downregulation of Sp100 (Fig. 3b, upper panel,  lanes 4 and 5) . However, it should be noted that the PMLkd observed with the double-kd cells was slightly reduced compared with the respective single-kd (Fig. 3b, middle  panel, compare lanes 3 and 5) . Then, the various cell lines were infected with HCMV AD169 (50 IEU), followed by the quantification of IE1-positive cells at 24 h p.i. (Fig. 3c,  e) . This experiment clearly revealed that the combined loss of either Sp100 with hDaxx or Sp100 with PML resulted in an additional enhancement of HCMV IE-gene expression efficacy compared with the respective single-kd cells. This was also observed in plaque assays that were performed in parallel (Fig. 3d, f) .
While several groups had demonstrated that PML and hDaxx can act as cellular restriction factors for HCMV replication, the function of Sp100 required further analysis. In this study, we could show that independent depletion of PML, hDaxx or Sp100 from HFFs resulted in a comparable increase of viral IE-gene expression and plaque formation. As already reported in previous studies, we observed that the kd of PML affected the abundance of low mobility isoforms of Sp100 (Everett et al., 2006, 2008) . In contrast to that, the loss of Sp100 neither had an impact on the subnuclear localization of PML nor on the isoform-specific expression pattern of PML. A recent study suggested that the SUMO-modification status of Sp100 is dependent on the presence of PML (Cuchet et al., 2011) . This raised the possibility that the improved replication of HCMV after depletion of PML could be explained by the loss of SUMOylated Sp100. However, since the combined kd of Sp100 and PML resulted in an additional enhancement of HCMV IE gene expression and plaque formation, this strongly argues for at least partially independent functions of PML and Sp100 for restriction of HCMV replication. Since several previous studies have implicated histone deacetylases (HDACs) in the mechanism by which the ND10 factor hDaxx represses viral gene expression (Saffert & Kalejta, 2006; Woodhall et al., 2006) , we investigated the effect of trichostatin A on HCMV IE gene expression in Sp100-depleted fibroblasts and control cells. However, this experiment did not reveal significant differences, which argues against an involvement of HDACs in Sp100-mediated repression (data not shown). Thus, the mechanism of Sp100-mediated silencing and the role of the different Sp100-isoforms will need further investigation. Nevertheless, the results of this study clearly demonstrate that PML, hDaxx as well as Sp100 can act as independent restriction factors for HCMV infection. In summary, the data strengthen the concept that ND10 structures are part of an antiviral defence mechanism of the cell, where different constituents of these structures, like Sp100, individually contribute to the repressive effect on HCMV replication.
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